Loading...
PhD Izidor Sosič

PhD Izidor Sosič
no.: 30816 source: ARIS

researcher – active in research organisation
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
897.27
A''
195.04
A'
508.6
A1/2
750.18
CI10
1,208
CImax
70
h10
20
A1
3.36
A3
0.08
Data for the last 5 years (citations for the last 10 years) on October 2, 2023; A3 for period 2017-2021 (update for tender in 2022: YES)
Data for ARIS tenders ( 14.06.2023 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 74  1,434  1,166  15.76 
Scopus 76  1,480  1,196  15.74 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Nika Strašek Benedik  Bologna doctoral studies  10/1/2020 - 9/30/2024  52378 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J1-4402  Dinamični model molekulskega stroja DNA topoizomeraze tipa II in razvoj katalitičnih inhibitorjev (Slovene)   2022 - 2023  PhD Andrej Perdih  2,515 
2. J1-4417  Razvoj novih nizkomolekularnih modulatorjev Tollu podobnih receptorjev 7 in 8 za imunoterapijo raka (Slovene)   2022 - 2023  PhD Matej Sova  3,777 
3. J1-4400  Vrednotenje prehodnih stanj proteinov (Slovene)   2022 - 2023  PhD Simona Golič Grdadolnik  3,097 
4. J3-3079  Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms   2021 - 2023  PhD Stane Pajk  2,280 
5. N1-0169  Kovalentni pristop k boju proti bakterijski rezistenci (Slovene)   2021 - 2023  PhD Stanislav Gobec  1,135 
6. J3-2517  Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants   2020 - 2023  PhD Žiga Jakopin  1,941 
7. J1-2485  The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs   2020 - 2023  PhD Izidor Sosič  894 
8. J1-1717  Development of novel Hsp90 inhibitors with anticancer activity   2019 - 2023  PhD Tihomir Tomašić  1,821 
9. J3-1745  Elucidating the role of immunoproteasome in platelet-driven immune response   2019 - 2023  PhD Martina Gobec  1,074 
10. Z1-7181  Optimization of nitroxoline-based inhibitors of cathepsin B as potential drugs for the treatment of cancer   2016 - 2017  PhD Izidor Sosič  239 
11. L1-6745  Combating bacterial resistance: optimisation of bacterial cell wall biosynthesis inhibitors   2014 - 2015  PhD Stanislav Gobec  3,167 
12. J1-6743  Computational tools development for modeling of pharmaceutically interesting molecules   2014 - 2015  PhD Dušanka Janežič  2,622 
13. J4-6811  The role of cysteine protease inhibitors in NK cell mediated lysis of tumour cells   2014 - 2015  PhD Janko Kos  2,378 
14. J4-5529  Nitroxoline and its derivatives as new antitumour drugs   2013 - 2015  PhD Janko Kos  5,764 
15. L1-4039  Preclinical development of new antibacterial drugs   2011  PhD Stanislav Gobec  4,049 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2022 - 2023  PhD Stanislav Gobec  5,120 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2015 - 2021  PhD Stanislav Gobec  5,770 
3. P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)   2009 - 2014  PhD Danijel Kikelj  5,653 
We were not given permission by the researcher to publish data.
Views history
Favourite